0001096906-22-002338.txt : 20220923 0001096906-22-002338.hdr.sgml : 20220923 20220923163532 ACCESSION NUMBER: 0001096906-22-002338 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220923 FILED AS OF DATE: 20220923 DATE AS OF CHANGE: 20220923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Rourke Peter CENTRAL INDEX KEY: 0001890749 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54296 FILM NUMBER: 221262723 MAIL ADDRESS: STREET 1: C/O NORTHVIEW ACQUISITION CORP. STREET 2: 207 WEST 25TH STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AXIM BIOTECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001514946 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274092986 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6191 CORNERSTONE COURT, E STREET 2: SUITE 114 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (212) 751-0001 MAIL ADDRESS: STREET 1: 6191 CORNERSTONE COURT, E STREET 2: SUITE 114 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AXIM INTERNATIONAL INC. DATE OF NAME CHANGE: 20110309 3 1 form3.xml PRIMARY DOCUMENT X0206 3 2022-09-23 0 0001514946 AXIM BIOTECHNOLOGIES, INC. AXIM 0001890749 O'Rourke Peter 6191 CORNERSTONE COURT, E. SUITE 114 SAN DIEGO CA 92121 1 0 0 0 Option 0.0520 2032-08-22 Common Stock 1000000.0000 D Reporting Person acquired an option to purchase up to 1,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date. /s/ Peter O'Rourke 2022-09-23